+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Increasing Mortality from Coronary Heart Disease among Males in Sweden

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          In Sweden, coronary heart disease (CHD) mortality increased by 30% among 50-to 54-year-old men and by 20% among 55- to 59-year-old men between 1968 and 1980. Among women there was no change during the same time. Two cohorts of 50-year-old men living in Gothenburg, Sweden, were examined 10 years apart (1963–1973). Levels of the 3 major CHD risk factors, blood pressure, serum cholesterol and smoking habits, were similar in these two cohorts. Men in the latest examined cohort had almost doubled the 7-year incidence of fatal and non-fatal CHD compared to men in the first examined cohort. Obesity was more prevalent among men examined in 1973 and also a significant risk factor for CHD in that cohort. Increased obesity and very slightly increased serum cholesterol levels can, however, only explain part of the increased incidence of CHD. Hypertension is being more effectively treated, the prevalence of smokers has decreased, and treatment of symptomatic CHD is similarly active in Sweden as in many other countries. Thus, several changes largely parallel those taking place in countries with decreasing CHD mortality. In spite of this, CHD mortality is increasing among males in Sweden. Possible reasons for this are discussed.

          Related collections

          Author and article information

          S. Karger AG
          11 November 2008
          : 72
          : 1-2
          : 75-80
          Departments of Medicine, Östra Hospital and Sahlgrenska Hospital, University of Göteborg, and Department of Family Medicine, Akademiska Hospital, University of Uppsala, Sweden
          173846 Cardiology 1985;72:75–80
          © 1985 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 6
          Changing Trends in Coronary Heart Disease Mortality. Possible Explanations


          Comment on this article